Date:
Drug courts are specialized courts that combine drug treatment with the legal and moral authority of the court in an effort to break the cycle of drug use and drug related crime.
Practice Goals
Drug courts aim to reduce recidivism and substance abuse among eligible people who have been convicted of nonviolent drug offenses. Drug courts require participants to abstain from drug and alcohol use, be accountable for their behavior, and fulfill the legal responsibilities of the offenses they committed. Ultimately, drug court programs are designed to rehabilitate people convicted of drug offenses and teach accountability. Often used as an alternative to incarceration (post-adjudication models), drug courts provide them an opportunity to receive treatment and education services designed to help them live crime-free lives, while still being closely monitored. Drugs courts may also operate as diversion programs (pre-adjudication models) where they are offered entry into the drug court with an agreement that the charges against them will be reduced or dismissed upon successful program completion.
Target Population
Adult drug court programs target adults age 18 and older. Demographically, the population is diverse. Eligibility criteria for entering a drug court program are determined by certain characteristics including offense type, criminal history, and substance abuse history. Typically, drug court programs do not allow violent individuals to participate.
Practice Components
In 1997, the National Association of Drug Court Professionals (NADCP) established six key components of drug courts: (1) collaborative, non-adversarial, outcome driven court processing; (2) early identification of eligible persons; (3) drug treatment integrated into criminal justice case processing; (4) urine testing; (5) judicial monitoring; and (6) the use of graduated sanctions/rewards (NADCP, 2012). Adult drug court treatment objectives are based on the six components that NADCP proposes.
The main components of drug court programs include screening participants for drugs and alcohol, ensuring participants comply with treatment, and making sure participants attend status hearings in order for judicial staff to monitor individual progress in court. Judicial staff collaborate with drug court staff to determine individual sanctions or rewards in response to a participant’s positive or negative behavior. Various rewards such as praise, tokens of achievement, or advancement to the next program phase are used to motivate progress. Sanctions may include increased treatment attendance, community service, or brief jail stays. It is up to each court’s discretion to determine which sanctions and awards are suitable for the situation.
If participants are compliant with program requirements, then advancement through three or more less intense stages occurs. Judicial and drug court staff members must decide if a participant has met the requirements of the phase necessary to progress.
If participants comply with program structure and complete mandated requirements, then successful completion is possible. The incentive to complete the program successfully is typically a reduced or dismissed charge.
Practice Theory
According to Shaffer (2011) drug court programs are based on the theoretical perspective of Therapeutic Jurisprudence (TJ). In a practical application of drug courts, this means that interactions between judicial staff and defendants, the structure and organization of the court proceedings, and legal rules and policies are all dealt with in a manner that encourages health and positive growth. TJ is applicable to drug court programs because the aim is to improve the lives of drug users. However, Shaffer cautions that while TJ is relevant to drug court programs, it does not prescribe what types of treatment should be provided to them outside of the courtroom setting.
For information on components that may impact the effectiveness of adult drug court programs, please see “Other Information.”
|
Crime & Delinquency | Multiple crime/offense types
Overall, the meta-analyses examining the effect of adult drug courts found that program participants were less likely to recidivate compared to those who did not participate. Synthesizing results across 26 studies, Aos and colleagues (2001) found a small negative mean effect size (d=-0.08), meaning that recidivism rates were, on average, lower for participants in drug court programs compared to individuals who did not enter into a drug court. Similarly, Drake (2012) analyzed 55 studies and also found a small negative effect (d=-0.25) showing a decrease in recidivism for program participants. Other studies have estimated the effect of drug courts using different methodologies. For instance, Shaffer (2010) used a phi coefficient to estimate the size of the program effect. The researchers calculated a small mean effect size (f=0.09) across 60 studies revealing a significant decrease in the recidivism of drug court participants compared to non-participants. Here a positive effect size suggests that, similar to the Aos and Drake findings, drug courts reduce recidivism rates compared to traditional criminal justice responses. Latimer and colleagues (2006), also using the phi coefficient, found a comparable small positive mean effect (f=0.16) in their review of 54 drug court studies. However, the findings were not significant. Analyzing results across 92 studies, Mitchell and colleagues (2012) used odds ratios to calculate the size of the program effect. In this study, the authors found a small to medium mean positive effect (OR=1.66) suggesting that compared to nonparticipants, recidivism rates among drug court participants were significantly lower. Finally, Sevigny, Fuleihan, and Ferdik (2013) found a significant moderate effect (logs odds ratio=-0.77) on recidivism (measured as reincarceration) favoring the treatment group. This means that relative to an assumed 50 percent incarceration rate for the comparison group, drug court participants had a 31.6 percent overall incarceration rate, or fewer than 184 incarcerations per 1,000 drug court participants. |
|
Crime & Delinquency | Drug and alcohol offenses
Mitchell and colleagues (2012) reviewed 42 studies that examined the effect of participating in a drug court program on drug-related offenses. The authors found a significant odds ratio of 1.7. This means that relative to a 50 percent recidivism rate in the comparison group (a typical value), the odds ratio translates into a recidivism rate of approximately 37 percent for drug court participants, meaning on average, drug court participants have a recidivism rate about 13 percentage points lower than nonparticipants. |
|
Drugs & Substance Abuse | Multiple substances
Mitchell and colleagues (2012) reviewed four studies that examined the effect of participating in a drug court program on drug use and found an odds ratio of 1.45, which indicates reduced drug use for drug court participants compared to nonparticipants. However, because of the small number of studies, the effect size was not significant. |
Several meta-analyses included additional tests—called moderator analyses--to see if any factors strengthened the likelihood that adult drug courts improved outcomes. Three moderator analyses assessed the impact of four factors on program effectiveness: program duration, leverage, program intensity, and population severity.
Program duration: Two analyses found that the duration of drug court programs had an impact on their effectiveness. Latimer and colleagues (2006) found that drug court programs that provided services for 1 year to 18 months demonstrated a significant reduction in recidivism compared with shorter or longer programs. Similarly, Shaffer (2006) found that drug courts designed to last between 8 and 16 months were significantly more effective than those designed to last less than 8 months or longer than 16 months.
Leverage (rewards and sanctions): Two analyses indicated that pre-adjudication models and post-adjudication models work equally for reducing recidivism. Both Mitchell and colleagues (2011) and Shaffer (2006) found that there were no significant differences between drug court programs that used a pre-adjudication model compared to those programs that use a post-adjudication model.
Program intensity: The findings on the impact of program intensity are mixed. Mitchell and colleagues found that drug court programs that had more than 2 status hearings a month had a significantly larger effect on drug-related recidivism than other courts (but no significant effect on general recidivism). Shaffer found overall mixed results. While some program requirements (restitution, education, and “other” requirements) were associated with reduced recidivism, other program requirements (community service, fines, and employment) were not.
Population severity: Two analyses found that program effects are bigger when programs serve populations with less severe problems. Mitchell and colleagues found that drug court programs that included only non-violent individuals had statistically larger effect sizes on general recidivism measures than programs that included violent individuals (the effect was not significant on drug-related recidivism). Shaffer also found that drug court programs that excluded violent individuals were significantly associated with reductions in recidivism.
These sources were used in the development of the practice profile:
Aos, Steve, Polly Phipps, Robert Barnoksi, and Roxanne Lieb. 2001. The Comparative Costs and Benefits of Programs to Reduce Crime. Version 4.0. Olympia, WA: Washington State Institute for Public Policy. View abstract
http://www.wsipp.wa.gov/rptfiles/costbenefit.pdfLatimer, Jeff, Kelly Morton-Bourgon, and Jo-Anne Chrétien. 2006. A Meta-Analytic Examination of Drug Treatment Courts: Do They Reduce Recidivism? Ottawa, Ontario: Department of Justice Canada, Research and Statistics Division. View abstract
http://www.justice.gc.ca/eng/rp-pr/csj-sjc/jsp-sjp/rr06_7/rr06_7.pdfMitchell, Ojmarrh, David Wilson, Amy Eggers, and Doris MacKenzie. 2012. “Drug Courts’ Effects on Criminal Offending for Juveniles and Adults.” Campbell Collaboration 4. View abstract
http://campbellcollaboration.org/lib/project/74/Shaffer, Deborah. 2006. Reconsidering Drug Court Effectiveness: A Meta-analytic Review. Las Vegas, NV: University of Las Vegas Department of Criminal Justice. View abstract
Drake, Elizabeth. 2012. Chemical Dependency: A Review of the Evidence and Benefit-Cost Findings. Olympia, WA: Washington State Institute for Public Policy. View abstract
http://www.wsipp.wa.gov/rptfiles/12-12-1201.pdfSevigny, Eric L., Brian K. Fuleihan, and Frank V. Ferdik. 2013. “Do Drug Courts Reduce the Use of Incarceration?: A Meta-Analysis.” Journal of Criminal Justice 41(6): 416–25. View abstract
These sources were used in the development of the practice profile:
National Association of Drug Court Professionals. 2012. "What are Drug Courts?” Web site, Alexandria, VA (accessed Mar. 20, 2013).
Longshore, Douglas, Susan W. Turner, Suzanne Wenzel, Andrew Morral, Adele Harrell, Duane McBridge, Elizabeth Deschenes, and Martin Iguchi. 2001. “Drug Courts: A Conceptual Framework.” Journal of Drug Issues 31(1):7–25.
Downey, P Mitchell, and John K. Roman. 2010. A Bayesian Meta-Analysis of Drug Court Cost-Effectiveness. Washington, D.C.: The Urban Institute, District of Columbia Crime Policy Institute.
Following are CrimeSolutions-rated programs that are related to this practice:
Age: 18 - 99
Gender: Male, Female
Race/Ethnicity: White, Other
Targeted Population: Alcohol and Other Drug (AOD) Offenders
Setting (Delivery): Courts
Practice Type: Alcohol and Drug Therapy/Treatment, Diversion
Unit of Analysis: Persons